Literature DB >> 676675

Tumor specific fluorescent and complement-dependent cytotoxic antibodies in the serum of rats with chemically induced brain gliomas.

D Stavrou, A P Anzil, H Elling.   

Abstract

Brain tumors were induced in Sprague-Dawley and Long-Evans rats by administration of N-methyl-N-nitrosourea in the drinking water. Of these tumors, a grade 2 mixed glioma, a grade 2 to 3 astrocytoma and a grade 1 to 2 oligodendroglioma were established in vitro, maintained in culture and designated 75SD-G-376, 75SD-G-420 and 77LE-G-180, respectively. Of these mass cultures, two were successfully cloned and are currently available as 75SD-G-376C and 75SD-G-420C cell lines. Clonal lines produce S-100 protein and grow as tumors when isografted in young rats. Using the cultured cells as target cells , specific antibodies were searched for in the sera of the rats with the primary tumors by means of an indirect fluorescent antibody staining method and a complement-dependent antibody-mediated microcytotoxicity assay. Fluorescent and cytotoxic antibodies were demonstrated in the sera of the mixed glioma- and astrocytoma-bearing animals. However, a variable proportion of cells of the 75SD-G-376 and 75SD-G-420 lines showed no reaction with the corresponding sera. Furthermore, cytotoxic antibodies had a lytic effect on the autologous glioma cells only in the presence of rabbit complement.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 676675     DOI: 10.1007/BF00685005

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  21 in total

1.  Histocompatibility antigens and tumor-specific transplantation antigens.

Authors:  E Appella; L W Law
Journal:  Exp Cell Biol       Date:  1976

2.  Cell-bound antiglial immunity in patients with malignant tumors of the brain.

Authors:  T Wahlström; E Saksela; H Troupp
Journal:  Cell Immunol       Date:  1973-02       Impact factor: 4.868

3.  Lysosome and phagosome stability in lethal cell injury. Morphologic tracer studies in cell injury due to inhibition of energy metabolism, immune cytolysis and photosensitization.

Authors:  H K Hawkins; J L Ericsson; P Biberfeld; B F Trump
Journal:  Am J Pathol       Date:  1972-08       Impact factor: 4.307

4.  In vitro demonstration of cell-mediated immunity to human brain tumors.

Authors:  N L Levy; M S Mahaley; E D Day
Journal:  Cancer Res       Date:  1972-03       Impact factor: 12.701

5.  Serologic cross-reactivity between H-2 and HL-A antigens. I. Specific reactivity of rabbit anti-HL-A sera against murine cells.

Authors:  D Götze; S Ferrone; R A Reisfeld
Journal:  J Immunol       Date:  1972-09       Impact factor: 5.422

6.  Human astrocytoma: serum-mediated immunologic response.

Authors:  P L Kornblith; F C Dohan; W C Wood; B O Whitman
Journal:  Cancer       Date:  1974-06       Impact factor: 6.860

7.  Lymphocytic infiltration in gliomas: evidence of possible host resistance.

Authors:  A Ridley; J B Cavanagh
Journal:  Brain       Date:  1971       Impact factor: 13.501

8.  Immunobiology of primary intracranial tumors. Part 1: studies of the cellular and humoral general immune competence of brain-tumor patients.

Authors:  M S Mahaley; W H Brooks; T L Roszman; D D Bigner; L Dudka; S Richardson
Journal:  J Neurosurg       Date:  1977-04       Impact factor: 5.115

9.  Selected morphological immunocytochemical and growth characteristics of three experimental rat gliomas and of their cells in vitro.

Authors:  D Stavrou; U Osterkamp; B Schröder; A P Anzil; K Zänker
Journal:  Exp Cell Biol       Date:  1979

10.  [Frequency and significance of lymphoplasmocyte infiltration in human gliomas (author's transl)].

Authors:  D Schiffer; G Croveri; C Pautasso
Journal:  Tumori       Date:  1974 May-Jun
View more
  2 in total

Review 1.  Monoclonal antibodies in neuro-oncology.

Authors:  D Stavrou
Journal:  Neurosurg Rev       Date:  1990       Impact factor: 3.042

2.  The immunological response of Wistar rats to the intracranially implanted C-6 glioma cell line.

Authors:  K M Chiu; J E Harris; J S Kroin; W Slayton; D P Braun
Journal:  J Neurooncol       Date:  1983       Impact factor: 4.130

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.